Incidence of cervical cancer after several negative smear results by age 50: Prospective observational study

BMJ (Online)

Volumn 338, Issue 7702, 2009, Pages 1058-1060

  Rebolj, Matejka ^a   Van Ballegooijen, Marjolein ^a   Lynge, Elsebeth ^b   Looman, Caspar ^a   Essink Bot, Marie Louise ^a   Boer, Rob ^a   Habbema, Dik ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SCREENING; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 67649097291     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b1354     Document Type: Article

References (42)

1. Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, et al. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer 2004;108:258-261 (Pubitemid 37541780)
2. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997;104:586-589 (Pubitemid 27240426)
3. Flannelly G, Monaghan J, Cruickshank M, Duncan I, Johnson J, Jordan J, et al. Cervical screening inwomen over the age of 50: results of a population-based multicentre study. Br J Obstet Gynaecol 2004;111:362-368 (Pubitemid 38446114)
4. Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995;63:804-809
5. Ogilvie D. Early discharge of low-riskwomen fromcervical screening. J Public Health Med 2001;23:272-277 (Pubitemid 34087289)
6. Van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ 1993;306:967-971 (Pubitemid 23100017)
7. Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, et al. Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial. Obstet Gynecol 2006;108:410-419 (Pubitemid 44305684)
8. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 2000;96:219-223 (Pubitemid 30447342)
9. Van Wijngaarden WJ, Duncan ID. Upper age limit for cervical screening. BMJ 1993;306:1409-1410 (Pubitemid 23144384)
10. Dutch Network and National Database for Pathology (PALGA). Results of retrieval action of cervix uteri tests until 31-03-2007. Utrecht: Prismant, 2007.
11. Van Oortmarssen GJ, Habbema JD. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1991;64:559-565
12. McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet 2008;9:425-434
13. PALGA. Description of the PALGA system and computer network. (In Dutch.) Utrecht, Netherlands: PALGA, 2004. www.palga.nl0
14. Van Ballegooijen M. Effects and costs of cervical cancer screening. Rotterdam, Netherlands: Department of Public Health, Erasmus University, 1998.
15. National Health Insurance Council. Starting points for the restructuring of the organised cervical cancer screening programme. Final decision. (In Dutch.) Amstelveen, Netherlands: Ziekenfonds Raad, 1993.
16. Rebolj M, van Ballegooijen M, Berkers LM, Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007;1206:806-812 (Pubitemid 46175400)
17. Akker-van Marle MEvd, van Ballegooijen M, Habbema JD. Low risk of cervical cancer during a long period after negative screening in the Netherlands. Br J Cancer 2003;88:1054-1057 (Pubitemid 36560775)
18. Rebolj M. Recent developments in the Dutch cervical cancer screening programme (thesis). Rotterdam: Department of Public Health, Erasmus MC, 2008.
19. Central Bureau of Statistics. Survival tables per sex and age. (In Dutch.) Voorburg/Heerlen, Netherlands: Centraal Bureau voor de Statistiek, 2008. http://statline.cbs.nl
20. Harrell FE. Regression modelling strategies. With applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.
21. Flannelly G, Bolger B, Fawzi H, De Lopes AB, Monaghan JM. Follow-up after LLETZ: could schedules be modified according to risk of recurrence? Br J Obstet Gynaecol 2001;108:1025-1030
22. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007;104:232-246 (Pubitemid 46054137)
23. Mitchell H, Hocking J. Influences on the risk of recurrent high grade cervical abnormality. Int J Gynecol Cancer 2002;12:728-734 (Pubitemid 35388041)
24. Pettersson F, Malker B. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry. Radiother Oncol 1989;16:115-120
25. Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-980 (Pubitemid 27149800)
26. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008;337:a1754.
27. Dutch Comprehensive Cancer Centres. Cancer registry online: core indicators. www.ikcnet.nl
28. Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives. J Med Screen 2005;12:7-11. (Pubitemid 40445070)
29. Gustafsson L, Ponten J, Bergstrom R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997;71:159-165 (Pubitemid 27252984)
30. Central Bureau of Statistics. Mortality, causes of death and euthanasia: life expectancy in years per sex in 2005. (In Dutch.) Voorburg/Heerlen, Netherlands: Centraal Bureau voor de Statistiek, 2007. http://statline.cbs.nl.
31. Rijke de JM, van der Putten HW, Lutgens LC, Voogd AC, Kruitwagen RF, van Dijck JA, et al. Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer 2002;38:2041-2047
32. Syrjanen S, Shabalova I, Petrovichev N, Podistov J, Ivanchenko O, Zakharenko S, et al. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union. Int J STD AIDS 2005;16:217-223 (Pubitemid 40469857)
33. Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, et al. Cervical human papillomavirus screening among older women. Emerg Infect Dis 2005;11:1680-1685 (Pubitemid 41628345)
34. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(suppl 1):S1-15.
35. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-585 (Pubitemid 23278262)
36. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93. (Pubitemid 36897941)
37. Cook GA, Draper GJ. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer 1984;50:367-375 (Pubitemid 14063889)
38. Van der Aa MA, de Kok IM, Siesling S, van Ballegooijen M, Coebergh JW. Does lowering the screening age for cervical cancer in The Netherlands make sense? Int J Cancer 2008;123:1403-1406
39. Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004;91:935-941 (Pubitemid 39273788)
40. Hawkes AP, Kronenberger CB, MacKenzie TD, Mardis AL, Palen TE, Schulter WW, et al. Cervical cancer screening: American College of Preventive Medicine practice policy statement. Am J Prev Med 1996;12:342-344 (Pubitemid 26376174)
41. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25. (Pubitemid 43228384)
42. US Preventive Services Task Force. Screening for cervical cancer - recommendations and rationale. www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr. htm.